1-7 of 7
Jorge Cortes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tyrosine kinase inhibitor for CML: all the same?

Clinical Trials & Observations
Lukas Veltmaat, Jorge Cortes
Journal: Blood Advances
Blood Adv (2024) 8 (20): 5339–5341.
https://doi.org/10.1182/bloodadvances.2024014060
Published: 2024
Journal Articles

Bringing global hematology research to the forefront

Global Advances
Andrés Gómez-De León, Andrés Noyola-Pérez, Lourdes Gil-Flores, Hemant Malhotra, Vasile Musteata, Amal El-Beshlawy, Hilman Tadjoedin, Carolina Pavlovsky, Jorge Cortes
Journal: Blood Advances
Blood Adv (2024) 8 (14): 3607–3611.
https://doi.org/10.1182/bloodadvances.2023011873
Published: 2024
Journal Articles

Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1 -mutated AML

Clinical Trials & Observations
Stéphane de Botton, Pierre Fenaux, Karen Yee, Christian Récher, Andrew H. Wei, Pau Montesinos, David C. Taussig, Arnaud Pigneux, Thorsten Braun, Antonio Curti, Carolyn Grove, Brian A. Jonas, Asim Khwaja, Ollivier Legrand, Pierre Peterlin, Montserrat Arnan, William Blum, Daniela Cilloni, Devendra K. Hiwase, Joseph G. Jurcic, Jürgen Krauter, Xavier Thomas, Justin M. Watts, Jay Yang, Olga Polyanskaya, Julie Brevard, Jennifer Sweeney, Emma Barrett, Jorge Cortes
Journal: Blood Advances
Blood Adv (2023) 7 (13): 3117–3127.
https://doi.org/10.1182/bloodadvances.2022009411
Published: 2023
Includes: Supplemental data
Journal Articles

Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel

Clinical Trials & Observations
Carolina Pavlovsky, Virginia Abello Polo, Katia Pagnano, Ana Ines Varela, Claudia Agudelo, Michele Bianchini, Carla Boquimpani, Renato Centrone, Monica Conchon, Nancy Delgado, Vaneuza Funke, Isabel Giere, Ingrid Luise, Luis Meillon, Beatriz Moiraghi, Juan Ramon Navarro, Lilian Pilleux, Ana Ines Prado, Soledad Undurraga, Jorge Cortes
Journal: Blood Advances
Blood Adv (2021) 5 (23): 4855–4863.
https://doi.org/10.1182/bloodadvances.2020003235
Published: 2021
Journal Articles

Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosis

Clinical Trials & Observations
Naveen Pemmaraju, Bing Z. Carter, Prithviraj Bose, Nitin Jain, Tapan M. Kadia, Guillermo Garcia-Manero, Carlos E. Bueso-Ramos, Courtney D. DiNardo, Sharon Bledsoe, Naval G. Daver, Uday Popat, Marina Y. Konopleva, Lingsha Zhou, Sherry Pierce, Zeev E. Estrov, Gautam M. Borthakur, Maro Ohanian, Wei Qiao, Lucia Masarova, Xuemei Wang, Po Yee Mak, Jorge Cortes, Elias Jabbour, Srdan Verstovsek
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3163–3173.
https://doi.org/10.1182/bloodadvances.2020003829
Published: 2021
Journal Articles

Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML

Clinical Trials & Observations
Nicholas J. Short, Hind Rafei, Naval Daver, Hyunsoo Hwang, Jing Ning, Jeffrey L. Jorgensen, Tapan M. Kadia, Courtney D. DiNardo, Sa A. Wang, Elias Jabbour, Uday Popat, Betul Oran, Jorge Cortes, Marina Konopleva, Musa Yilmaz, Ghayas C. Issa, Hagop Kantarjian, Farhad Ravandi
Journal: Blood Advances
Blood Adv (2020) 4 (24): 6117–6126.
https://doi.org/10.1182/bloodadvances.2020002811
Published: 2020
Includes: Supplemental data
Journal Articles

Co-occurrence of FLT3 -TKD and NPM1 mutations defines a highly favorable prognostic AML group

Clinical Trials & Observations
Prajwal Boddu, Hagop Kantarjian, Gautam Borthakur, Tapan Kadia, Naval Daver, Sherry Pierce, Michael Andreeff, Farhad Ravandi, Jorge Cortes, Steven M. Kornblau
Journal: Blood Advances
Blood Adv (2017) 1 (19): 1546–1550.
https://doi.org/10.1182/bloodadvances.2017009019
Published: 2017
Includes: Supplemental data